Publication | Closed Access

Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology

Alzheimer's DiseaseDegenerative PathologyEarly TreatmentNeurologyNeuroscienceNeurodegenerationBrain PathologyMedicineAlzheimer-like Amyloid PathologyTransgenic Rat ModelLewy Body Dementia